Search Results 111-120 of 17409 for methyldopa

  1. https://www.mayoclinic.org/arabic_procedure_concepts.xml

  2. Breast cancer - Doctors and departments - Mayo Clinic

    Learn about this common cancer, including information on prevention, symptoms, diagnosis and treatment.

  3. Breast cancer - Doctors and departments - Mayo Clinic

    Learn about this common cancer, including information on prevention, symptoms, diagnosis and treatment.

  4. Text Messaging Smoking Cessation Program in Surgical Patients - Mayo Clinic

    Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

  5. Breast cancer - Doctors and departments - Mayo Clinic

    Learn about this common cancer, including information on prevention, symptoms, diagnosis and treatment.

  6. Endocrinology - Doctors - Mayo Clinic

    Endocrinology at Mayo Clinic offers treatment and specialty care for people with a wide range of rare and common endocrine disorders.

  7. A Study To Evaluate The Safety And Effectiveness Of BIIB054 In Subjects With Parkinson’s Disease - Mayo Clinic

    ... methyldopa. Use of any of the following medications within 90 days before Day 1: methylphenidate, cinnarizine, tetrabenazine, reserpine, amphetamine ...

  8. A Study To Evaluate APG2575 Combined With Novel Therapeutic Regimens To Treat Subjects With Relapsed Or Refractory Multiple Myeloma And Immunoglobulin Light Chain Amyloidosis - Mayo Clinic

    About this study. The purpose of this study is to evaluate the safety and tolerability, identify dose-limiting toxicities (DLT) and the maximum tolerated ...

  9. A Study To Evaluate The Safety And Tolerability Of HMPL-306 To Treat Advanced Or Metastatic Solid Tumors With IDH Mutations - Mayo Clinic

    Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

  10. Pivotal 1 Study Of ABBV-RGX-314 (Also Known As RGX-314) Gene Therapy Administered Via Subretinal Delivery One Time In Participants With NAMD - Mayo Clinic

    Current anti-vascular endothelial growth factor (anti-VEGF) therapies have significantly changed the landscape for treatment of wet AMD, becoming the standard ...